Clinical Trials in Detroit

Showing 8881-8900 of 19,719 trials

Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer

NCT01022138

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Treating a patient's T cells in the laboratory may help the T cells kill more tumor cells when they are put back in the body. Giving laboratory-treated T cells after chemotherapy may be an effective treatment for breast cancer. PURPOSE: This phase II trial is studying how well giving laboratory-treated T cells after second-line chemotherapy works in treating patients with HER2/neu-negative metastatic breast cancer.

Breast Cancer

Barbara Ann Karmanos Cancer Institute43 participantsStarted Mar 2010

Detroit, Michigan, United States

COMPLETEDPhase 3< 1 mile

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

NCT03528551

This study will look at how a known study medicine N8-GP works in previously N8-GP treated people with haemophilia A. The aim is to look at how N8-GP works during regular use. Participants will get N8-GP. N8-GP has been tested in more than 200 people with haemophilia A for several years. Participants will get an injection of N8-GP into a blood vessel, one, two or three times weekly. Participants will get more doses if they bleed or if they will need a surgery. The study will last for about 2 years. Participants will have at least 9 visits with the study doctor. If participants agree to be in this study, they will get their first injection (in this study) at the first visit. Participants will also get an injection at visit 3, 5 and 7. Participants will be trained to give all other injections themselves. Participants must not use any clotting factors other than N8-GP or any anticoagulants (blood thinners) during the study.

Congenital Bleeding DisorderHaemophilia A

Novo Nordisk A/S160 participantsStarted Apr 2018

Phoenix, Arizona, United States • Long Beach, California, United States • Iowa City, Iowa, United States +64 more locations

Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

Find Trials by Condition in Detroit

Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects

Mood Lifters: A Self Help Program

Neurobiological Effects of Light on MDD

An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis

An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion

Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection

Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Formula Tolerance of Term Infants

Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.

ESTIA: Computerized Intervention Targeting Cognitive Control Deficits in Depressed Adults